News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SMC Biotechnology Announces Publication of Bone Repair Data


7/10/2013 9:15:29 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

REDWOOD CITY, Calif., July 10, 2013 (GLOBE NEWSWIRE) -- SMC Biotechnology, a regenerative medicine company focused on developing carbohydrate compounds that enhance tissue regeneration, announced today that data published in the online journal, Biomaterials, suggests that its proprietary sugar compound, SMC-103 greatly enhances bone repair. Researchers found that affinity-selected heparan sulfate (HS) improved bone repair by increasing the bioavailability, bioactivity and half-life of the pro-healing compound, bone morphogenetic protein-2 (BMP-2). SMC-103 is a glycosaminoglycan, or GAG, a naturally occurring substance composed of chains of paired sugar units. SMC Biotechnology is currently developing SMC-103 as a bone-healing device that can be delivered to the exact site of injury or damage to augment the body's natural healing process.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES